14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 21, 2024 Buy 23 491 Garber Alan M Common Stock
Mar 21, 2024 Sell 19 205 Garber Alan M Common Stock
Mar 21, 2024 Sell 23 491 Garber Alan M Option (right to buy)
Feb 23, 2024 Buy 82 121 Peterson Amy C. Common Stock
Feb 23, 2024 Buy 63 350 Aftab Dana Common Stock
Feb 23, 2024 Buy 241 670 Morrissey Michael Common Stock
Feb 23, 2024 Buy 82 121 Senner Christopher J. Common Stock
Feb 23, 2024 Buy 63 350 Hessekiel Jeffrey Common Stock
Feb 23, 2024 Buy 63 350 Haley Patrick J. Common Stock
Feb 23, 2024 Sell 47 020 Haley Patrick J. Common Stock
Feb 21, 2024 Buy 190 000 Johnson David Edward Common Stock
Feb 15, 2024 Sell 10 630 Aftab Dana Common Stock
Jan 11, 2024 Buy 250 374 Morrissey Michael Common Stock
Jan 11, 2024 Sell 63 717 Morrissey Michael Common Stock
Jan 11, 2024 Buy 80 186 Senner Christopher J. Common Stock
Jan 11, 2024 Sell 21 862 Senner Christopher J. Common Stock
Jan 11, 2024 Buy 71 418 Hessekiel Jeffrey Common Stock
Jan 11, 2024 Sell 13 061 Hessekiel Jeffrey Common Stock
Jan 11, 2024 Buy 74 462 Haley Patrick J. Common Stock
Jan 11, 2024 Sell 13 613 Haley Patrick J. Common Stock
Jan 11, 2024 Buy 63 224 Aftab Dana Common Stock
Jan 11, 2024 Sell 11 606 Aftab Dana Common Stock
Jan 05, 2024 Buy 30 848 Eckhardt Sue Gail Option (right to buy)
Jan 05, 2024 Buy 15 424 Eckhardt Sue Gail Common Stock
Jan 05, 2024 Buy 30 848 Beckerle Mary C Option (right to buy)
Jan 05, 2024 Buy 15 424 Beckerle Mary C Common Stock
Jan 05, 2024 Buy 0 Eckhardt Sue Gail
Jan 05, 2024 Buy 0 Beckerle Mary C
Dec 14, 2023 Buy 50 000 Haley Patrick J. Common Stock
Dec 14, 2023 Sell 50 000 Haley Patrick J. Common Stock
Dec 14, 2023 Sell 50 000 Haley Patrick J. Option (right to buy)
Dec 13, 2023 Sell 25 000 Hessekiel Jeffrey Common Stock
Dec 12, 2023 Sell 14 149 Haley Patrick J. Common Stock
Dec 04, 2023 Sell 25 000 Hessekiel Jeffrey Common Stock
Nov 30, 2023 Sell 25 000 Hessekiel Jeffrey Common Stock
Nov 27, 2023 Buy 120 409 Johnson David Edward Common Stock
Nov 27, 2023 Sell 120 409 Johnson David Edward Common Stock
Nov 16, 2023 Sell 19 020 Morrissey Michael Common Stock
Nov 07, 2023 Buy 116 893 Morrissey Michael Common Stock
Nov 07, 2023 Sell 116 893 Morrissey Michael Common Stock
Sep 06, 2023 Buy 188 005 Morrissey Michael Common Stock
Sep 06, 2023 Sell 46 608 Morrissey Michael Common Stock
Sep 06, 2023 Buy 65 135 Senner Christopher J. Common Stock
Sep 06, 2023 Sell 17 147 Senner Christopher J. Common Stock
Sep 06, 2023 Buy 50 660 Aftab Dana Common Stock
Sep 06, 2023 Sell 12 560 Aftab Dana Common Stock
Sep 06, 2023 Buy 57 900 Haley Patrick J. Common Stock
Sep 06, 2023 Sell 14 354 Haley Patrick J. Common Stock
Sep 06, 2023 Buy 57 900 Hessekiel Jeffrey Common Stock
Sep 06, 2023 Sell 14 354 Hessekiel Jeffrey Common Stock
Sep 01, 2023 Sell 57 500 Morrissey Michael Common Stock
Aug 31, 2023 Buy 56 221 Morrissey Michael Common Stock
Aug 31, 2023 Sell 56 221 Morrissey Michael Common Stock
Aug 30, 2023 Sell 4 600 Aftab Dana Common Stock
Aug 28, 2023 Buy 360 000 Morrissey Michael Common Stock
Aug 28, 2023 Sell 303 779 Morrissey Michael Common Stock
Aug 28, 2023 Sell 360 000 Morrissey Michael Option (right to buy)
Aug 24, 2023 Buy 240 000 Peterson Amy C. Common Stock
Aug 24, 2023 Buy 160 000 Peterson Amy C. Option (right to buy)
Aug 24, 2023 Buy 0 Peterson Amy C.
Aug 15, 2023 Sell 23 304 Morrissey Michael Common Stock
Aug 15, 2023 Sell 8 074 Senner Christopher J. Common Stock
Aug 15, 2023 Sell 7 177 Hessekiel Jeffrey Common Stock
Aug 15, 2023 Sell 7 177 Haley Patrick J. Common Stock
Aug 15, 2023 Sell 6 280 Aftab Dana Common Stock
Aug 04, 2023 Buy 60 000 Senner Christopher J. Common Stock
Aug 04, 2023 Sell 60 000 Senner Christopher J. Common Stock
Aug 04, 2023 Sell 60 000 Senner Christopher J. Option (right to buy)
Aug 03, 2023 Sell 60 000 Senner Christopher J. Common Stock
Aug 03, 2023 Sell 60 000 Senner Christopher J. Option (right to buy)
Aug 03, 2023 Sell 30 553 Haley Patrick J. Common Stock
Aug 01, 2023 Buy 55 710 Hessekiel Jeffrey Common Stock
Aug 01, 2023 Sell 55 710 Hessekiel Jeffrey Common Stock
Aug 01, 2023 Sell 55 710 Hessekiel Jeffrey Option (right to buy)
Jun 01, 2023 Buy 44 087 Garber Alan M Option (right to buy)
Jun 01, 2023 Buy 20 718 Freire Maria C Common Stock
Jun 01, 2023 Buy 20 718 Poste George Common Stock
Jun 01, 2023 Buy 20 718 Wright Jacqueline Common Stock
Jun 01, 2023 Buy 20 718 Wyszomierski Jack L Common Stock
Jun 01, 2023 Buy 20 718 Papadopoulos Stelios Common Stock
Jun 01, 2023 Buy 44 087 Smith Julie Option (right to buy)
May 31, 2023 Buy 36 353 Oliver Bob Option (right to buy)
May 31, 2023 Buy 18 176 Oliver Bob Common Stock
May 31, 2023 Buy 36 353 Heyman Tomas J. Option (right to buy)
May 31, 2023 Buy 18 176 Heyman Tomas J. Common Stock
May 31, 2023 Buy 0 Heyman Tomas J.
May 31, 2023 Buy 0 Oliver Bob
May 31, 2023 Buy 36 353 Johnson David Edward Option (right to buy)
May 31, 2023 Buy 18 176 Johnson David Edward Common Stock
May 31, 2023 Buy 0 Johnson David Edward Common Stock, par value $0.001 per share
May 15, 2023 Sell 4 940 Hessekiel Jeffrey Common Stock
May 15, 2023 Sell 7 027 Hessekiel Jeffrey Common Stock
May 15, 2023 Sell 8 444 Senner Christopher J. Common Stock
May 15, 2023 Sell 10 002 Senner Christopher J. Common Stock
May 15, 2023 Sell 33 518 Morrissey Michael Common Stock
May 15, 2023 Sell 4 373 Aftab Dana Common Stock
May 15, 2023 Sell 6 115 Aftab Dana Common Stock
May 15, 2023 Sell 3 026 Haley Patrick J. Common Stock
May 15, 2023 Sell 6 274 Haley Patrick J. Common Stock
May 15, 2023 Sell 8 765 Haley Patrick J. Common Stock
INSIDER POWER
26.385
Last 100 transactions
Buy: 3 435 845 | Sell: 2 083 268 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 26.385.

In total, the insiders bought 3 435 845 and sold 2 083 268 EXEL shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT